Catalent Inc (CTLT)

$58.68 0.23 (0.39%)

19:00 EDT CTLT Stock Quote Delayed 30 Minutes

CTLT Stock Earnings: Catalent Misses EPS, Misses Revenue for Q3 2024

By InvestorPlace Earnings May 9, 2024

CTLT stock results show that Catalent missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024.

Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Volume:

Previous Close -

Market Cap 10.00B

PE Ratio -9.98

EPS -5.88

Volume (Avg. Vol.) 3.00M

Day's Range $58.29 - $58.72

52-Week Range $31.80 - $60.20

Dividend & Yield N/A (N/A)

CTLT Stock Predictions, Articles, and Catalent Inc News

3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late

By Will Ashworth, InvestorPlace Contributor Sep 7, 2023

S&P 500 companies collectively saw second-quarter earnings fall by 4% over last year. A big problem for the index constituents is the higher interest expenses…

Catalent (CTLT) Stock Gains on Elliott Deal

By William White, InvestorPlace Writer Aug 29, 2023

Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management.

CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent

By William White, InvestorPlace Writer Jul 20, 2023

Catalent (CTLT) stock is on the move Thursday as investors react to activist investor Elliott Investment taking a stake in the company.

Catalent (CTLT) Stock Surges Despite Second Earnings Delay

By Josh Enomoto, InvestorPlace Contributor May 19, 2023

Although Catalent again delayed its earnings release, CTLT stock managed to pop higher on management’s update on the matter.

CTLT Stock Sinks 25% After Catalent Delays Earnings Release

By Josh Enomoto, InvestorPlace Contributor May 8, 2023

With embattled biotech firm Catalent delaying its earnings disclosure for one week, the severe loss of credibility hurt CTLT stock.

Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?

By Larry Ramer, InvestorPlace Contributor Feb 6, 2023

Catalent (CTLT) stock is soaring more than 20% in early trading on a report that Danaher was interested in buying CTLT.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 6, 2023

We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday!

Why Is Catalent (CTLT) Stock Down 24% Today?

By William White, InvestorPlace Writer Nov 1, 2022

Catalent (CTLT) stock is falling on Tuesday as investors react to dismal results in its earnings report for the fiscal first quarter of 2023.

7 Healthcare Stocks to Add to Your Portfolio

By Steve Booyens, CFA Oct 6, 2021

Healthcare stocks could take over from energy stocks as top dog during this defensive cycle as yields move higher and tech stocks lose value.

7 Growth Stocks With Compelling Stories

By Tezcan Gecgil, InvestorPlace Contributor Mar 17, 2021

Despite occasional pullbacks in share price, these growth stocks are expected to continue to create shareholder value during the year.

Why Investors Should Take Another Look at Moderna’s Many Advantages

By Chris Lau, InvestorPlace Contributor Jul 10, 2020

After a solid run since starting at the sub-$20 levels at the start of the year, Moderna (NASDAQ:MRNA) continues to attract plenty of buying and…

10 Small-Cap, Up-And-Coming Stocks to Keep on Your Radar

By James Brumley, InvestorPlace Feature Writer Aug 21, 2019

Qorvo, Catalent and XPO Logistics are just some of the up-and-coming stocks too many investors are still overlooking.

5 Drug Stocks Poised to Surpass on Earnings This Quarter

By Apr 17, 2018

The outlook for the upcoming first-quarter results looks bright. Compare Brokers....

M&A News: Catalent Inc (CTLT) to Buy Cook Pharmica in $950M Deal

By William White, InvestorPlace Writer Sep 19, 2017

Catalent (CTLT) is planning to acquire Cook Pharmica for $950 million in a deal that is expected to close in the fourth quarter of 2017.

3 Stocks to Watch on Tuesday: Nike Inc (NKE), Finish Line Inc (FINL) and Catalent Inc (CTLT)

By Karl Utermohlen, InvestorPlace Writer Aug 29, 2017

Finish Line (FINL) is cratering Tuesday on a profit warning, Nike (NKE) is getting dragged down yet again and Catalent (CTLT) is enjoying a big earnings pop.

11 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 28, 2016

The ratings of 11 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

11 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 21, 2016

This week, the overall grades of 11 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – RTRX EVOK RETA AAOI

By Portfolio Grader Sep 7, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Catalent Inc (CTLT)

CTLT Stock Earnings: Catalent Misses EPS, Misses Revenue for Q3 2024

Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Catalent Inc (CTLT)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

CTLT Stock Predictions, Articles, and Catalent Inc News

Subscriber Sign in